Medical oversight, proper sourcing, and lab monitoring are essential before and during use
Horm Res 48 (Suppl 5): S105S110 Rudling M et al
Arent the severity and the variety of symptoms different in each patient
Your appetite when discontinuing AOD-9604 will be the same as before starting, making transitions on and off the peptide straightforward without the metabolic complications of appetite rebound
Contact your GP if you notice no improvement after 46 weeks of treatment, experience worsening neurological symptoms, or develop new unexpected symptoms
Pushing through with a dose increase typically makes symptoms worse, not better, and can lead to treatment discontinuation, which defeats the entire purpose of the graduated approach